A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months

BACKGROUND: VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions. OBJECTIVE: To evaluate 12-month effectiveness and safety of VYC-17.5L for the treatment of moderate/severe nasolabial folds (NLFs). METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dermatol Surg
Main Authors: Sattler, Gerhard, Philipp-Dormston, Wolfgang G., Van Den Elzen, Helga, Van Der Walt, Cornelius, Nathan, Myooran, Kolodziejczyk, Julia, Kerson, Graeme, Dhillon, Benjeev
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414733/
https://ncbi.nlm.nih.gov/pubmed/28165349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/DSS.0000000000000939
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados